Long-Term Outcomes of Peripheral Drug-Eluting Stents

doi:N/A

Contents

Abstract
Keywords

Download XML

4 Views

0 Downloads

Share this article

Research Article | Volume 31 Issue 1 (January - March, 2026) | Pages 1 - 2

Long-Term Outcomes of Peripheral Drug-Eluting Stents

Matthew R. Collins

. Sophia L. Bennett

Daniel K. Morgan

Emily R. Carter

⁴

Ahmed N. Rahman

⁵

Department of Vascular and Endovascular Medicine, Metropolitan Heart Institute, New York, USA

Division of Cardiovascular Intervention, University Hospital London, UK

Department of Vascular Research, Global Cardiac Sciences Centre, Sydney, Australia

⁴

Department of Cardiovascular Imaging, European Vascular Institute, Berlin, Germany

⁵

Department of Interventional Cardiology, International Vascular Research Foundation, Dubai, UAE

Under a Creative Commons license

Open Access

Abstract

Peripheral drug-eluting stents have improved outcomes in selected patients with peripheral artery disease by reducing restenosis and repeat revascularization compared with plain balloon angioplasty and bare-metal stents. This article reviews long-term efficacy, patency, safety, restenosis patterns, limb outcomes, and clinical implications of drug-eluting stents in femoropopliteal and infrapopliteal arterial disease.

Keywords

Peripheral Artery Disease

Drug-Eluting Stents

Femoropopliteal Disease

Restenosis

Patency

Limb Salvage

Download PDF